Application note: Ultrapure water for LC-MS biomedical analyses

In this paper the suitability of reagent water for LC-MS biomedical analyses will be evaluated and the role of water quality in achieving sensitive and reliable LC-MS analyses will be discussed.

Furthermore, since quality assurance is one of the key requirements in the clinical laboratory, a modern solution for data management will be introduced in order to address this need.

The power of LC-MS is recognized by biomedical laboratories worldwide. Nowadays modern LC–MS instrumentation ranges from research to routine use in clinical laboratories and is effectively applied in such areas as:

• Therapeutic drug monitoring – measure of drugs (e.g., immunosuppressants) in plasma, blood or tissues
• Drugs of abuse testing – measure of drugs (e.g., cannabis, methadone, amphetamine, morphine, meperidine,
  etc.) in urine or saliva
• Hormone testing – measure of hormones (e.g., steroids or thyroid hormones) in serum or plasma
• Biogenic amine analysis – measure of biogenic amines (e.g., catecholamines) in plasma or urine
• Neonatal screening – detection of treatable disorders in infants by monitoring amino acid and acylcarnitine
  levels using LC-MS

Please read and download the full Application Note below:

[pdf-embedder url=”https://www.europeanpharmaceuticalreview.com/wp-content/uploads/1-Merck-App-note-Ultrapure-Water-for-LC-MS-Biomedical-Analyses-1.pdf” title=”1 Merck – App note – Ultrapure Water for LC-MS Biomedical Analyses”]